MENTOR, Ohio -- STERIS Corporation today announced that it has completed the decontamination of a United States Department of State mail processing facility located in Sterling, Va. using the company's proprietary technology and services. The building has now been re-opened for normal use following a very stringent environmental assessment of the facility, using approved Centers for Disease Control and Prevention (CDC) standards.
The 1.4-million-cubic-foot facility was contaminated with Bacillus anthracis spores (the causative agent of anthrax) after accepting mail that originated from the Brentwood, Washington, D.C. postal facility in October 2001. STERIS provided the decontamination technology and related support services through its subsidiary, Strategic Technologies Enterprises, Inc. This remediation program provided the opportunity for various governmental agencies to validate the STERIS proprietary VHP process for large-scale decontamination.
STERIS' decontamination technology was selected for use in this project after the Department of State's Technical Working Group (TWG) compared and evaluated available remediation technologies. The TWG included representatives from the State Department, the Environmental Protection Agency, CDC, Occupational Health and Safety Administration, Army Corps of Engineers, commonwealth of Virginia, and other local, state, and federal agencies. Evaluation criteria included efficacy, safety, materials compatibility and industry experience with the technology. The Company developed a comprehensive remedial decontamination plan and health and safety protocols that were deployed in the successful decontamination of the facility. As part of the decontamination plan, the Company supplied quality and sterility assurance protocols. STERIS' proprietary decontamination technology produces environmentally friendly by-products, namely water and oxygen, which were important criteria in the governmental selection process.
The technology used to decontaminate the facility is similar to technology STERIS has provided to pharmaceutical and research customers for more than a decade, modified by the company for application in large-scale, complex, building interiors. The technology has been proven effective at eliminating anthrax and other dangerous pathogens, and has been used previously to decontaminate facilities and other items by both government and industrial customers.
Source: STERIS Corporation
Top 7 Infection Control Today Articles of 2024: Insights and Innovations
December 30th 2024From advanced sterilization methods to combating antimicrobial resistance, Infection Control Today’s top articles of 2024 delivered actionable strategies for safer healthcare environments and improved patient outcomes.
Redefining Competency: A Comprehensive Framework for Infection Preventionists
December 19th 2024Explore APIC’s groundbreaking framework for defining and documenting infection preventionist competency. Christine Zirges, DNP, ACNS-BC, CIC, FAPIC, shares insights on advancing professional growth, improving patient safety, and navigating regulatory challenges.
Tackling Health Care-Associated Infections: SHEA’s Bold 10-Year Research Plan to Save Lives
December 12th 2024Discover SHEA's visionary 10-year plan to reduce HAIs by advancing infection prevention strategies, understanding transmission, and improving diagnostic practices for better patient outcomes.
Environmental Hygiene: Air Pressure and Ventilation: Negative vs Positive Pressure
December 10th 2024Learn more about how effective air pressure regulation in health care facilities is crucial for controlling airborne pathogens like tuberculosis and COVID-19, ensuring a safer environment for all patients and staff.
Pioneering Advances in Sterilization: The Future of Infection Control
November 28th 2024Germitec, STERIS, ASP, and Zuno Medical are pioneering sterilization advancements with groundbreaking technologies that enhance SPD workflows, improve patient safety, and redefine infection control standards.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.